Publications
Our statistical team have demonstrated their proficiency in a number of scientific publications:
- Safety, tolerability, and immunogenicity of SPVX02, a room temperature-stabilised tetanus-diphtheria vaccine, compared to two established tetanus-diphtheria booster vaccines
Read more - EDP-938, a Respiratory Syncytial Virus Inhibitor, in a Human Virus Challenge
Read more - In vitro and clinical data demonstrate negligible risk of drug–drug interactions with opelconazole, a novel inhaled antifungal agent
Read more - Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults
Read more - Human Challenge Trial of a Nucleoside-Modified Messenger Ribonucleic Acid Influenza Vaccine
Read more - Development and validation of the IPF Coughing Severity Scale v2© (IPF CSS v2): a simple patient reported outcome measure (PROM) for assessing cough severity in IPF
Read more - Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption
Read more - Postvaccination C-Reactive Protein and C5/gp41732-744 Antibody Level Fold-Changes Over Baseline Are Independent Predictors of Therapeutic HIV Vaccine Effect in a Phase 2 Clinical Study of Vacc-4x
Read more - A case for preART-adjusted endpoints in HIV therapeutic vaccine trials
Read more